Ignite Creation Date:
2025-12-24 @ 9:36 PM
Ignite Modification Date:
2026-01-01 @ 3:20 PM
Study NCT ID:
NCT03642132
Status:
TERMINATED
Last Update Posted:
2023-04-06
First Post:
2018-07-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-19
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-22
Completion Date Type:
ACTUAL
First Submit Date:
2018-07-13
First Submit QC Date:
None
Study First Post Date:
2018-08-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-12-06
Results First Submit QC Date:
None
Results First Post Date:
2023-04-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-10
Last Update Post Date:
2023-04-06
Last Update Post Date Type:
ACTUAL